Tech Company Financing Transactions

Scorpion Therapeutics Funding Round

Boxer Capital, EcoR1 Capital Management and Omega Funds joined a $162 million Series B funding round for Scorpion Therapeutics. The round was announced by the company on 1/8/2021.

Transaction Overview

Announced On
1/8/2021
Transaction Type
Venture Equity
Amount
$162,000,000
Round
Series B
Investors

Boxer Capital (Lead Investor) (Aaron Davis)

EcoR1 Capital Management (Lead Investor) (Oleg Nodelman)

Omega Funds (Lead Investor) (Otello Stampacchia)

Vida Ventures (Lead Investor) (Arjun Goyal)

Abingworth

Atlas Venture

Casdin Capital

Invus

Janus Henderson Investors

Logos Capital

Nextech Invest

OrbiMed

Surveyor Capital

Wellington Management Company

Woodline Partners

Proceeds Purpose
This financing will enable us to increase our investment in our platform technologies and programs, as we execute with equal parts urgency and rigor to transform the standard-of-care in cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
888 Boylston St. 1111
Boston, MA 02199
USA
Email Address
Overview
At Scorpion Therapeutics, we are working to expand the reach of precision medicine to more people with cancer, including cancers that are untreatable or treatment-resistant today. We are moving with equal parts urgency and rigor to change the status quo, drawing on our team's expertise and drive to accelerate our impact on patients.
Profile
Scorpion Therapeutics LinkedIn Company Profile
Social Media
Scorpion Therapeutics Company Twitter Account
Company News
Scorpion Therapeutics News
Facebook
Scorpion Therapeutics on Facebook
YouTube
Scorpion Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gary Glick
  Gary Glick LinkedIn Profile  Gary Glick Twitter Account  Gary Glick News  Gary Glick on Facebook
Chief Scientific Officer
Darrin Stuart
  Darrin Stuart LinkedIn Profile  Darrin Stuart Twitter Account  Darrin Stuart News  Darrin Stuart on Facebook
Executive Vice President
Erica Jackson
  Erica Jackson LinkedIn Profile  Erica Jackson Twitter Account  Erica Jackson News  Erica Jackson on Facebook
VP - Bus. Development
Lina Gugucheva
  Lina Gugucheva LinkedIn Profile  Lina Gugucheva Twitter Account  Lina Gugucheva News  Lina Gugucheva on Facebook
VP - General Counsel
Joseph Campisi
  Joseph Campisi LinkedIn Profile  Joseph Campisi Twitter Account  Joseph Campisi News  Joseph Campisi on Facebook
VP - Human Resources
Amanda Valentino
  Amanda Valentino LinkedIn Profile  Amanda Valentino Twitter Account  Amanda Valentino News  Amanda Valentino on Facebook
VP - Operations
Adam Friedman
  Adam Friedman LinkedIn Profile  Adam Friedman Twitter Account  Adam Friedman News  Adam Friedman on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2021: Spectrum Effect venture capital transaction
Next: 1/8/2021: Kira Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary